Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
Cancer Chemotherapy and Pharmacology|May 28, 2015
A phase II study of biweekly S-1 and paclitaxel (SPA) as first-line chemotherapy in patients with metastatic or advanced gastric cancerHaiping Jiang, Jiong Qian, Peng Zhao, et al.
Signal Transduction and Targeted Therapy|April 4, 2023
tRF-Gln-CTG-026 ameliorates liver injury by alleviating global protein synthesisSunyang Ying, Pengcheng Li, Jiaqiang Wang, et al.
Journal of Thoracic Disease|March 8, 2014
A study of weekly docetaxel and carboplatin as first-line chemotherapy for advanced non-small cell lung cancerHaiping Jiang, Xiaochen Zhang, Jing Chen, et al.
Signal Transduction and Targeted Therapy|April 18, 2020
PD-L1 is a direct target of cancer-FOXP3 in pancreatic ductal adenocarcinoma (PDAC), and combined immunotherapy with antibodies against PD-L1 and CCL5 is effective in the treatment of PDACXiuchao Wang, Xin Li, Xunbin Wei, et al.
Biomaterials|October 17, 2021
Prodrug nanoparticles rationally integrating stroma modification and chemotherapy to treat metastatic pancreatic cancerLiying Wang, Zimo Liu, Quan Zhou, et al.
Advanced Materials (Deerfield Beach, Fla.)|April 18, 2024
Neutrophil Extracellular Traps-Inhibiting and Fouling-Resistant Polysulfoxides Potently Prevent Postoperative Adhesion, Tumor Recurrence, and MetastasisJiafeng Wang, Yechun Wang, Junjun Li, et al.
Mabs|August 13, 2019
Durable blockade of PD-1 signaling links preclinical efficacy of sintilimab to its clinical benefitJie Wang, Keke Fei, Hua Jing, et al.
Gynecologic Oncology|September 19, 2025
Sacituzumab govitecan in Chinese patients with recurrent/metastatic cervical cancer: Results from the phase 2 EVER-132-003 basket study (NCT05119907)Jusheng An, Guiling Li, Yunyan Zhang, et al.
Therapeutic Advances in Medical Oncology|July 14, 2025
Camrelizumab plus SOX chemotherapy as adjuvant therapy for pathological stage III gastric or gastroesophageal junction adenocarcinoma: a prospective, multicenter, single-arm, phase II trialHailong Jin, Jiren Yu, Yuan Gao, et al.
Stem Cell Reports|May 10, 2024
Functional mouse hepatocytes derived from interspecies chimeric livers effectively mitigate chronic liver fibrosisCheng Huang, Haiping Jiang, Jingxi Dong, et al.
Pageof 10